Clinical trial

Randomised Controlled Trial Assessing the Impact of Genital Herpes Suppressive Therapy on HIV Shedding

NCT00158509

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Valacyclovir Normalized identity: valacyclovirView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Randomised Controlled Trial Assessing the Impact of Genital Herpes Suppressive Therapy on HIV Shedding

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2004-08-01

PhasePHASE2

Conditions

Herpes Genitalisverified · MONDO: genital herpes

HIV Infectionverified · MONDO: HIV infectious disease

Interventions

ValacyclovirDRUG · verified · RxNorm: valacyclovir

Sponsors & collaborators

French National Agency for Research on AIDS and Viral Hepatitislead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00158509 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.